Current Pharmaceutical DesignCurrent Pharmaceutical DesignCurrent Pharmaceutical Design1381-61281873-4286Bentham Science64598910.2174/0113816128319149240812103715Immunology, Inflammation & AllergyResearch ArticleNetwork Pharmacology Analysis and Retrospective Cohort Study Revealing the Effect of Qingyi Decoction on Intestinal Paralysis in Patients with Severe Acute PancreatitisDuShihaninfo@benthamscience.netZhaoDinghuaninfo@benthamscience.netSongKaiinfo@benthamscience.netZhangYuaninfo@benthamscience.netWuLinainfo@benthamscience.netWangBeiinfo@benthamscience.netLiYaninfo@benthamscience.netYuJianboinfo@benthamscience.netDepartment of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical UniversityDepartment of Anesthesiology, Tianjin Eye Hospital1011202430423322333811012025Copyright ©; 2024, Bentham Science Publishers2024Bentham Science Publishershttps://journals.eco-vector.com/1381-6128/article/view/645989

Background:Intestinal dysfunction plays an important role in the clinical progress and prognosis of severe acute pancreatitis (SAP). Qingyi decoction (QYD) has shown beneficial effects on intestinal function recovery, but the prevention actions of the QYD on intestinal paralysis and its mechanism have not been fully explored.

Methods:The possible molecular mechanism was unraveled by network pharmacology, including active ingredients and potential target prediction, as well as GO, KEGG, and REATCOME pathway enrichment analyses. The potential interactions between the main active ingredients of the QYD and core genes were explored by molecular docking. A retrospective cohort study on 137 patients with SAP from Tianjin Nankai Hospital was conducted to evaluate the preventive effect of QYD on intestinal paralysis.

Results:A total of 110 active ingredients in QYD were screened out, and 37 key targets were predicted by network pharmacology. GO, KEGG, and REATCOME enrichment analyses showed that bioinformatics annotation of the hub genes was mainly involved in intestinal epithelial functions and inflammatory response pathways. The main components of QYD possessed good affinity with IL-6, TNF, CASP3, CXCL8, and CRP by molecular docking. Patients who used QYD plus usual care seemed to have fewer intestinal paralysis rates, lower risk of renal insufficiency, ARDS and blood purification therapy, and shorter hospital and ICU stays. The multivariable regression analyses indicated that the mode of nasogastric and enemas administration of QYD (P = 0.010) and timely intervention with QYD (P = 0.045) were the independent protective factors for intestinal paralysis prevention in patients with SAP.

Conclusion:In conclusion, QYD can be used as an effective adjuvant procedure to prevent the occurrence and development of intestinal paralysis in patients with SAP. The mechanisms may be involved in the anti-inflammatory response and maintenance of intestinal epithelial function.

Severe acute pancreatitisintestinal paralysisQingyi decoctionnetwork pharmacologymolecular dockinginflammation.Banks PA, Bollen TL, Dervenis C, et al. Acute pancreatitis classification working group. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62(1): 102-11. doi: 10.1136/gutjnl-2012-302779 PMID: 23100216Nesvaderani M, Eslick GD, Vagg D. Epidemiology, aetiology and outcomes of acute pancreatitis: A retrospective cohort study. Int J Surg 2015; 23(Pt A): 68-74. doi: 10.1016/j.ijsu.2015.07.701 PMID: 26384834Forsmark CE, Swaroop Vege S, Wilcox CM. Acute pancreatitis. N Engl J Med 2016; 375(20): 1972-81. doi: 10.1056/NEJMra1505202 PMID: 27959604Petrov MS, Shanbhag S, Chakraborty M, Phillips ARJ, Windsor JA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 2010; 139(3): 813-20. doi: 10.1053/j.gastro.2010.06.010 PMID: 20540942Agarwal S, George J, Padhan RK, et al. Reduction in mortality in severe acute pancreatitis: A time trend analysis over 16 years. Pancreatology 2016; 16(2): 194-9. doi: 10.1016/j.pan.2016.01.012 PMID: 26915280Capurso G, Zerboni G, Signoretti M, et al. Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol 2012; 46 (Suppl.): S46-51. doi: 10.1097/MCG.0b013e3182652096 PMID: 22955357Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 2003; 7(1): 26-36. doi: 10.1016/S1091-255X(02)00090-2 PMID: 12559182Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9(11): 799-809. doi: 10.1038/nri2653 PMID: 19855405Iacubovici L, Karol D, Baar Y, et al. Assessment of intra-abdominal pressure with a novel continuous bladder pressure monitor-A clinical validation study. Life 2023; 13(2): 384. doi: 10.3390/life13020384 PMID: 36836741Liu H, Li W, Wang X, Li J, Yu W. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 2008; 36(2): 192-6. doi: 10.1097/MPA.0b013e31815a399f PMID: 18376312Ge P, Luo Y, Okoye CS, et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis. Biomed Pharmacother 2020; 132: 110770. doi: 10.1016/j.biopha.2020.110770 PMID: 33011613Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ 2019; 367: l6227. doi: 10.1136/bmj.l6227 PMID: 31791953Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: The substantial human and financial costs. Gut 1998; 42(6): 886-91. doi: 10.1136/gut.42.6.886 PMID: 9691932Zhu F, Yin S, Zhou L, et al. Chinese herbal medicine Xuebijing injection for acute pancreatitis: An overview of systematic reviews. Front Pharmacol 2022; 13: 883729. doi: 10.3389/fphar.2022.883729 PMID: 36034818Fang J, Wei H, Sun Y, et al. Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule). BMC Complement Altern Med 2013; 13(1): 76. doi: 10.1186/1472-6882-13-76 PMID: 23560927Yang C, Wang T, Chen J, et al. Traditional Chinese medicine formulas alleviate acute pancreatitis. Pancreas 2021; 50(10): 1348-56. doi: 10.1097/MPA.0000000000001931 PMID: 35041332Ling C, Yue X, Ling C. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J Integr Med 2014; 12(4): 331-5. doi: 10.1016/S2095-4964(14)60038-8 PMID: 25074882Xiao M, Tian J, Zhou Y, et al. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial. Pharmacol Res 2020; 161: 105126. doi: 10.1016/j.phrs.2020.105126 PMID: 32781283Luo E, Zhang D, Luo H, et al. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei province, China. Chin Med 2020; 15(1): 34. doi: 10.1186/s13020-020-00317-x PMID: 32308732Yang Z, Liu Y, Wang L, et al. Traditional Chinese medicine against COVID-19: Role of the gut microbiota. Biomed Pharmacother 2022; 149: 112787. doi: 10.1016/j.biopha.2022.112787 PMID: 35279010Li J, Zhang S, Zhou R, Zhang J, Li ZF. Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis. World J Gastroenterol 2017; 23(20): 3615-23. doi: 10.3748/wjg.v23.i20.3615 PMID: 28611514Wang G, Shang D, Zhang G, et al. Effects of QingYi decoction on inflammatory markers in patients with acute pancreatitis: A meta- analysis. Phytomedicine 2022; 95: 153738. doi: 10.1016/j.phymed.2021.153738 PMID: 34544631Wang GY, Shang D, Zhang GX, et al. Qingyi decoction attenuates intestinal epithelial cell injury via the calcineurin/nuclear factor of activated T-cells pathway. World J Gastroenterol 2022; 28(29): 3825-37. doi: 10.3748/wjg.v28.i29.3825 PMID: 36157544Zhang JW, Zhang GX, Chen HL, et al. Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury. World J Gastroenterol 2015; 21(12): 3537-46. doi: 10.3748/wjg.v21.i12.3537 PMID: 25834318Syed RU, Moni SS, Lila ASA, et al. Spectral analysis and antiulcer potential of Lactuca sativa through the amelioration of proinflammatory cytokines and apoptosis markers. Life 2022; 12(10): 1641. doi: 10.3390/life12101641 PMID: 36295076Bindea G, Mlecnik B, Hackl H, et al. ClueGO: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009; 25(8): 1091-3. doi: 10.1093/bioinformatics/btp101 PMID: 19237447Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg 2019; 14(1): 27. doi: 10.1186/s13017-019-0247-0 PMID: 31210778Cazacu S, Parscoveanu M, Cartu D, et al. NLR48 is better Than CRP, and mCTSI, and similar to BISAP and SOFA scores for mortality prediction in acute pancreatitis: A comparison of 6 scores. J Inflamm Res 2023; 16: 4793-804. doi: 10.2147/JIR.S432408 PMID: 37881651Choi YH, Jang DK, Lee SH, et al. Utility of serum phosphate as a marker for predicting the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis. United European Gastroenterol J 2018; 6(6): 895-901. doi: 10.1177/2050640618764168 PMID: 30023067Huang Z, Ma X, Jia X, et al. Prevention of severe acute pancreatitis with cyclooxygenase-2 inhibitors: A randomized controlled clinical trial. Am J Gastroenterol 2020; 115(3): 473-80. doi: 10.14309/ajg.0000000000000529 PMID: 32142484Holani R, Babbar A, Blyth GAD, et al. Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production. Gut Microbes 2020; 12(1): 1785802. doi: 10.1080/19490976.2020.1785802 PMID: 32658599Maheshwari A, Lacson A, Lu W, et al. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr Res 2004; 56(2): 240-9. doi: 10.1203/01.PDR.0000133196.25949.98 PMID: 15181190Lin WS, Chueh TL, Nagabhushanam K, Ho CT, Pan MH. Piceatannol and 3′-hydroxypterostilbene alleviate inflammatory bowel disease by maintaining intestinal epithelial integrity and regulating gut microbiota in mice. J Agric Food Chem 2023; 71(4): 1994-2005. doi: 10.1021/acs.jafc.2c08170 PMID: 36688924Tian R, Tan JT, Wang RL, Xie H, Qian YB, Yu KL. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis. Eur Rev Med Pharmacol Sci 2013; 17(3): 349-55. PMID: 23426538Bai Y, Liu Y, Jia L, et al. Severe acute pancreatitis in China: Etiology and mortality in 1976 patients. Pancreas 2007; 35(3): 232-7. doi: 10.1097/MPA.0b013e3180654d20 PMID: 17895843Van Acker GJD, Weiss E, Steer ML, Perides G. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292(6): G1738-46. doi: 10.1152/ajpgi.00543.2006 PMID: 17332471Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology 2019; 156(7): 2008-23. doi: 10.1053/j.gastro.2018.12.041 PMID: 30768987Papachristou GI. Prediction of severe acute pancreatitis: Current knowledge and novel insights. World J Gastroenterol 2008; 14(41): 6273-5. doi: 10.3748/wjg.14.6273 PMID: 19009638Whitcomb DC. Acute pancreatitis. N Engl J Med 2006; 354(20): 2142-50. doi: 10.1056/NEJMcp054958 PMID: 16707751Habtezion A, Gukovskaya AS, Pandol SJ. Acute pancreatitis: A multifaceted set of organelle and cellular interactions. Gastroenterology 2019; 156(7): 1941-50. doi: 10.1053/j.gastro.2018.11.082 PMID: 30660726Samuel I. Bile and pancreatic juice exclusion activates acinar stress kinases and exacerbates gallstone pancreatitis. Surgery 2008; 143(3): 434-40. doi: 10.1016/j.surg.2007.06.004 PMID: 18291265Ding L, Chen HY, Wang JY, et al. Severity of acute gastrointestinal injury grade is a good predictor of mortality in critically ill patients with acute pancreatitis. World J Gastroenterol 2020; 26(5): 514-23. doi: 10.3748/wjg.v26.i5.514 PMID: 32089627Liao R, Xue L, Qiang Z, Zhang C, Liu Y. Release of endogenous hydrogen sulfide in enteric nerve cells suppresses intestinal motility during severe acute pancreatitis. Acta Biochim Biophys Sin 2019; 52(1): 64-71. doi: 10.1093/abbs/gmz139 PMID: 31889183Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas 2003; 26(2): 122-9. doi: 10.1097/00006676-200303000-00006 PMID: 12604908Li XY, He C, Zhu Y, Lu NH. Role of gut microbiota on intestinal barrier function in acute pancreatitis. World J Gastroenterol 2020; 26(18): 2187-93. doi: 10.3748/wjg.v26.i18.2187 PMID: 32476785Lu QG, Zeng L, Li XH, et al. Protective effects of panax notoginseng saponin on dextran sulfate sodium-induced colitis in rats through phosphoinositide-3-kinase protein kinase B signaling pathway inhibition. World J Gastroenterol 2020; 26(11): 1156-71. doi: 10.3748/wjg.v26.i11.1156 PMID: 32231420Escobar J, Pereda J, Arduini A, et al. Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: A key role for protein phosphatases. Curr Pharm Des 2009; 15(26): 3027-42. doi: 10.2174/138161209789058075 PMID: 19754377Zhongkai L, Jianxin Y, Weichang C. Vasoactive intestinal peptide promotes gut barrier function against severe acute pancreatitis. Mol Biol Rep 2012; 39(4): 3557-63. doi: 10.1007/s11033-011-1129-z PMID: 21725849Guo NK, She H, Tan L, et al. Nano parthenolide improves intestinal barrier function of sepsis by inhibiting apoptosis and ROS via 5-HTR2A. Int J Nanomedicine 2023; 18: 693-709. doi: 10.2147/IJN.S394544 PMID: 36816330Li H, Xie J, Guo X, et al. Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses. Gut Microbes 2022; 14(1): 2127456. doi: 10.1080/19490976.2022.2127456 PMID: 36195972Korada SK, Yarla NS, Bishayee A, et al. Can probiotics cure inflammatory bowel diseases? Curr Pharm Des 2016; 22(7): 904-17. doi: 10.2174/1381612822666151209153249 PMID: 26648465Song G, Liu D, Geng X, et al. Bone marrow-derived mesenchymal stem cells alleviate severe acute pancreatitis-induced multiple-organ injury in rats via suppression of autophagy. Exp Cell Res 2019; 385(2): 111674. doi: 10.1016/j.yexcr.2019.111674 PMID: 31678171Besselink MGH, van Santvoort HC, Buskens E, et al. Dutch acute pancreatitis study group. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 2008; 371(9613): 651-9. doi: 10.1016/S0140-6736(08)60207-X PMID: 18279948Tenner S, Baillie J, Dewitt J. American college of gastroenterology guideline: Management of acute pancreatitis. Am J Gastroenterol 2013; 108(9): 1400-500. doi: 10.1038/ajg.2013.218Schizodimos T, Soulountsi V, Iasonidou C, Kapravelos N. An overview of management of intracranial hypertension in the intensive care unit. J Anesth 2020; 34(5): 741-57. doi: 10.1007/s00540-020-02795-7 PMID: 32440802Rahimi RS, Singal AG, Cuthbert JA, Rockey DC. Lactulose vs. polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: The HELP randomized clinical trial. JAMA Intern Med 2014; 174(11): 1727-33. doi: 10.1001/jamainternmed.2014.4746 PMID: 25243839Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 2007; 3(7): 360-6. doi: 10.1038/nchembio0707-360 PMID: 17576417Chen W, Yang X, Huang L, et al. Qing-Yi decoction in participants with severe acute pancreatitis: A randomized controlled trial. Chin Med 2015; 10(1): 11. doi: 10.1186/s13020-015-0039-8 PMID: 26029248Wei TF, Zhao L, Huang P, et al. Qing-Yi decoction in the treatment of acute pancreatitis: An integrated approach based on chemical profile, network pharmacology, molecular docking and experimental evaluation. Front Pharmacol 2021; 12: 590994. doi: 10.3389/fphar.2021.590994 PMID: 33995005Ergin E, Oruç N, Ersöz G, Tekeşin O, Özütemiz Ö. Prognosis and risk factors of ERCP pancreatitis in elderly. Sci Rep 2021; 11(1): 15930. doi: 10.1038/s41598-021-95484-8 PMID: 34354184Marie S, Alhejji KA, Bin Gheshayan S, Bin Nafesah S, Al Selaim N. Dual bowel obstruction: A rare case of gallstone ileus and colonic adenocarcinoma. Cureus 2022; 14(1): e21379. doi: 10.7759/cureus.21379 PMID: 35198291Reisner RM, Cohen JR. Gallstone ileus: A review of 1001 reported cases. Am Surg 1994; 60(6): 441-6. PMID: 8198337Sapci I, Hameed I, Ceylan A, et al. Predictors of ileus following colorectal resections. Am J Surg 2020; 219(3): 527-9. doi: 10.1016/j.amjsurg.2019.10.002 PMID: 31604485Lu Z, Chen X, Ge H, et al. Neutrophil-lymphocyte ratio in patients with hypertriglyceridemic pancreatitis predicts persistent organ failure. Gastroenterol Res Pract 2022; 2022: 1-8. doi: 10.1155/2022/8333794 PMID: 35340692Matta B, Gougol A, Gao X, et al. Worldwide variations in demographics, management, and outcomes of acute pancreatitis. Clin Gastroenterol Hepatol 2020; 18(7): 1567-1575.e2. doi: 10.1016/j.cgh.2019.11.017 PMID: 31712075Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: Clinical and pathophysiological implications. Gut 2000; 47(4): 546-52. doi: 10.1136/gut.47.4.546 PMID: 10986216Chen KL, Lv ZY, Yang HW, et al. Effects of tocilizumab on experimental severe acute pancreatitis and associated acute lung injury. Crit Care Med 2016; 44(8): e664-77. doi: 10.1097/CCM.0000000000001639 PMID: 26963319Giovannoni F, Quintana FJ. The role of astrocytes in CNS inflammation. Trends Immunol 2020; 41(9): 805-19. doi: 10.1016/j.it.2020.07.007 PMID: 32800705Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998; 9(1): 9-23. doi: 10.1016/S1359-6101(97)00022-1 PMID: 9720753García-Marchena N, Araos PF, Barrios V, et al. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity. Front Psychiatry 2017; 7: 214. doi: 10.3389/fpsyt.2016.00214 PMID: 28149283van den Berg FF, Kempeneers MA, van Santvoort HC, Zwinderman AH, Issa Y, Boermeester MA. Meta-analysis and field synopsis of genetic variants associated with the risk and severity of acute pancreatitis. BJS Open 2020; 4(1): 3-15. doi: 10.1002/bjs5.50231 PMID: 32011822Zhou Q, Xiang H, Liu H, et al. Emodin alleviates intestinal barrier dysfunction by inhibiting apoptosis and regulating the immune response in severe acute pancreatitis. Pancreas 2021; 50(8): 1202-11. doi: 10.1097/MPA.0000000000001894 PMID: 34714285Tai WP, Lin XC, Liu H, et al. A retrospective research of the characteristic of hypertriglyceridemic pancreatitis in Beijing, China. Gastroenterol Res Pract 2016; 2016: 1-4. doi: 10.1155/2016/6263095 PMID: 26880892Zheng Y, Zhou Z, Li H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas 2015; 44(3): 409-14. doi: 10.1097/MPA.0000000000000273 PMID: 25438072Cao L, Chen Y, Liu S, et al. Chinese acute pancreatitis clinical trials group (CAPCTG). Early plasmapheresis among patients with hypertriglyceridemia-associated acute pancreatitis. JAMA Netw Open 2023; 6(6): e2320802. doi: 10.1001/jamanetworkopen.2023.20802 PMID: 37378979